The Pharmaceutical Paradox — Field Guide to the North American Pharmaceutical Market
The North American pharmaceutical industry is nothing if not a study in contrasts. By some measures, industry performance is very robust. Revenue growth is strong, patients are increasingly being treated based on their individual genetic makeup, and the industry’s scientific understanding continues to grow by the day.
On the other hand, the industry is challenged. It is facing fierce pricing-control pressures, R&D productivity is declining, and core industry business models have been forever changed.
This paper seeks to explore these issues so that the industry might come together to address the challenges, yet capitalize on some of the greatest opportunities it has ever experienced, and, most importantly, so that the industry might continue to collaborate to further patient health and wellness.